Alternative p38 MAPKs Are Essential for Collagen‐Induced Arthritis

Objective The role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38γ and p38δ deficiency in the collagen‐induced arthritis (CIA) model. Methods Wild‐type, p38γ−/−, p38δ−/−, and p38γ/δ−/− mice were immunized with chicken type II collagen, and...

Full description

Saved in:
Bibliographic Details
Published inArthritis & rheumatology (Hoboken, N.J.) Vol. 66; no. 5; pp. 1208 - 1217
Main Authors Criado, Gabriel, Risco, Ana, Alsina‐Beauchamp, Dayanira, Pérez‐Lorenzo, María J., Escós, Alejandra, Cuenda, Ana
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.05.2014
Subjects
Online AccessGet full text
ISSN2326-5191
2326-5205
2326-5205
DOI10.1002/art.38327

Cover

Abstract Objective The role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38γ and p38δ deficiency in the collagen‐induced arthritis (CIA) model. Methods Wild‐type, p38γ−/−, p38δ−/−, and p38γ/δ−/− mice were immunized with chicken type II collagen, and disease activity was evaluated by semiquantitative scoring and histologic assessment. Serum cytokine levels and in vitro T cell cytokine responses were quantified by flow cytometry and multiplex analysis, and serum anticollagen antibody levels by enzyme‐linked immunosorbent assay. Cytokine and p38 MAPK isoform expression in joints were determined by quantitative polymerase chain reaction. Results Compound p38γ and p38δ deficiency markedly reduced arthritis severity compared with that in wild‐type mice, whereas lack of either p38γ or p38δ had an intermediate effect. Joint damage was minimal in arthritic p38γ/δ−/− mice compared with wild‐type mice. The p38γ/δ−/− mice had lower levels of pathogenic anticollagen antibodies and interleukin‐1β (IL‐1β) and tumor necrosis factor α than controls. In vitro T cell assays showed reduced proliferation, interferon‐γ (IFNγ) production, and IL‐17 production by lymph node cells from p38γ/δ−/− mice. IL‐17 and IFNγ messenger RNA expression in joints was significantly inhibited in p38γ/δ−/− mice. Wild‐type chimeric mice with p38γ/δ−/− bone marrow did not show decreased CIA. Conclusion Reduced disease severity in p38γ/δ−/− mice was associated with lower cytokine production and anticollagen antibody responses than in controls, indicating that p38γ and p38δ are crucial regulators of inflammatory joint destruction in CIA. Our findings indicate that p38γ and p38δ are potential therapeutic targets in complex diseases, such as rheumatoid arthritis, that involve innate and adaptive immune responses.
AbstractList Objective The role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38γ and p38δ deficiency in the collagen‐induced arthritis (CIA) model. Methods Wild‐type, p38γ−/−, p38δ−/−, and p38γ/δ−/− mice were immunized with chicken type II collagen, and disease activity was evaluated by semiquantitative scoring and histologic assessment. Serum cytokine levels and in vitro T cell cytokine responses were quantified by flow cytometry and multiplex analysis, and serum anticollagen antibody levels by enzyme‐linked immunosorbent assay. Cytokine and p38 MAPK isoform expression in joints were determined by quantitative polymerase chain reaction. Results Compound p38γ and p38δ deficiency markedly reduced arthritis severity compared with that in wild‐type mice, whereas lack of either p38γ or p38δ had an intermediate effect. Joint damage was minimal in arthritic p38γ/δ−/− mice compared with wild‐type mice. The p38γ/δ−/− mice had lower levels of pathogenic anticollagen antibodies and interleukin‐1β (IL‐1β) and tumor necrosis factor α than controls. In vitro T cell assays showed reduced proliferation, interferon‐γ (IFNγ) production, and IL‐17 production by lymph node cells from p38γ/δ−/− mice. IL‐17 and IFNγ messenger RNA expression in joints was significantly inhibited in p38γ/δ−/− mice. Wild‐type chimeric mice with p38γ/δ−/− bone marrow did not show decreased CIA. Conclusion Reduced disease severity in p38γ/δ−/− mice was associated with lower cytokine production and anticollagen antibody responses than in controls, indicating that p38γ and p38δ are crucial regulators of inflammatory joint destruction in CIA. Our findings indicate that p38γ and p38δ are potential therapeutic targets in complex diseases, such as rheumatoid arthritis, that involve innate and adaptive immune responses.
Objective The role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38[gamma] and p38[delta] deficiency in the collagen-induced arthritis (CIA) model. Methods Wild-type, p38[gamma]-/-, p38[delta]-/-, and p38[gamma]/[delta]-/- mice were immunized with chicken type II collagen, and disease activity was evaluated by semiquantitative scoring and histologic assessment. Serum cytokine levels and in vitro T cell cytokine responses were quantified by flow cytometry and multiplex analysis, and serum anticollagen antibody levels by enzyme-linked immunosorbent assay. Cytokine and p38 MAPK isoform expression in joints were determined by quantitative polymerase chain reaction. Results Compound p38[gamma] and p38[delta] deficiency markedly reduced arthritis severity compared with that in wild-type mice, whereas lack of either p38[gamma] or p38[delta] had an intermediate effect. Joint damage was minimal in arthritic p38[gamma]/[delta]-/- mice compared with wild-type mice. The p38[gamma]/[delta]-/- mice had lower levels of pathogenic anticollagen antibodies and interleukin-1[beta] (IL-1[beta]) and tumor necrosis factor [alpha] than controls. In vitro T cell assays showed reduced proliferation, interferon-[gamma] (IFN[gamma]) production, and IL-17 production by lymph node cells from p38[gamma]/[delta]-/- mice. IL-17 and IFN[gamma] messenger RNA expression in joints was significantly inhibited in p38[gamma]/[delta]-/- mice. Wild-type chimeric mice with p38[gamma]/[delta]-/- bone marrow did not show decreased CIA. Conclusion Reduced disease severity in p38[gamma]/[delta]-/- mice was associated with lower cytokine production and anticollagen antibody responses than in controls, indicating that p38[gamma] and p38[delta] are crucial regulators of inflammatory joint destruction in CIA. Our findings indicate that p38[gamma] and p38[delta] are potential therapeutic targets in complex diseases, such as rheumatoid arthritis, that involve innate and adaptive immune responses.
The role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38γ and p38δ deficiency in the collagen-induced arthritis (CIA) model.OBJECTIVEThe role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38γ and p38δ deficiency in the collagen-induced arthritis (CIA) model.Wild-type, p38γ(-/-) , p38δ(-/-) , and p38γ/δ(-/-) mice were immunized with chicken type II collagen, and disease activity was evaluated by semiquantitative scoring and histologic assessment. Serum cytokine levels and in vitro T cell cytokine responses were quantified by flow cytometry and multiplex analysis, and serum anticollagen antibody levels by enzyme-linked immunosorbent assay. Cytokine and p38 MAPK isoform expression in joints were determined by quantitative polymerase chain reaction.METHODSWild-type, p38γ(-/-) , p38δ(-/-) , and p38γ/δ(-/-) mice were immunized with chicken type II collagen, and disease activity was evaluated by semiquantitative scoring and histologic assessment. Serum cytokine levels and in vitro T cell cytokine responses were quantified by flow cytometry and multiplex analysis, and serum anticollagen antibody levels by enzyme-linked immunosorbent assay. Cytokine and p38 MAPK isoform expression in joints were determined by quantitative polymerase chain reaction.Compound p38γ and p38δ deficiency markedly reduced arthritis severity compared with that in wild-type mice, whereas lack of either p38γ or p38δ had an intermediate effect. Joint damage was minimal in arthritic p38γ/δ(-/-) mice compared with wild-type mice. The p38γ/δ(-/-) mice had lower levels of pathogenic anticollagen antibodies and interleukin-1β (IL-1β) and tumor necrosis factor α than controls. In vitro T cell assays showed reduced proliferation, interferon-γ (IFNγ) production, and IL-17 production by lymph node cells from p38γ/δ(-/-) mice. IL-17 and IFNγ messenger RNA expression in joints was significantly inhibited in p38γ/δ(-/-) mice. Wild-type chimeric mice with p38γ/δ(-/-) bone marrow did not show decreased CIA.RESULTSCompound p38γ and p38δ deficiency markedly reduced arthritis severity compared with that in wild-type mice, whereas lack of either p38γ or p38δ had an intermediate effect. Joint damage was minimal in arthritic p38γ/δ(-/-) mice compared with wild-type mice. The p38γ/δ(-/-) mice had lower levels of pathogenic anticollagen antibodies and interleukin-1β (IL-1β) and tumor necrosis factor α than controls. In vitro T cell assays showed reduced proliferation, interferon-γ (IFNγ) production, and IL-17 production by lymph node cells from p38γ/δ(-/-) mice. IL-17 and IFNγ messenger RNA expression in joints was significantly inhibited in p38γ/δ(-/-) mice. Wild-type chimeric mice with p38γ/δ(-/-) bone marrow did not show decreased CIA.Reduced disease severity in p38γ/δ(-/-) mice was associated with lower cytokine production and anticollagen antibody responses than in controls, indicating that p38γ and p38δ are crucial regulators of inflammatory joint destruction in CIA. Our findings indicate that p38γ and p38δ are potential therapeutic targets in complex diseases, such as rheumatoid arthritis, that involve innate and adaptive immune responses.CONCLUSIONReduced disease severity in p38γ/δ(-/-) mice was associated with lower cytokine production and anticollagen antibody responses than in controls, indicating that p38γ and p38δ are crucial regulators of inflammatory joint destruction in CIA. Our findings indicate that p38γ and p38δ are potential therapeutic targets in complex diseases, such as rheumatoid arthritis, that involve innate and adaptive immune responses.
The role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38γ and p38δ deficiency in the collagen-induced arthritis (CIA) model. Wild-type, p38γ(-/-) , p38δ(-/-) , and p38γ/δ(-/-) mice were immunized with chicken type II collagen, and disease activity was evaluated by semiquantitative scoring and histologic assessment. Serum cytokine levels and in vitro T cell cytokine responses were quantified by flow cytometry and multiplex analysis, and serum anticollagen antibody levels by enzyme-linked immunosorbent assay. Cytokine and p38 MAPK isoform expression in joints were determined by quantitative polymerase chain reaction. Compound p38γ and p38δ deficiency markedly reduced arthritis severity compared with that in wild-type mice, whereas lack of either p38γ or p38δ had an intermediate effect. Joint damage was minimal in arthritic p38γ/δ(-/-) mice compared with wild-type mice. The p38γ/δ(-/-) mice had lower levels of pathogenic anticollagen antibodies and interleukin-1β (IL-1β) and tumor necrosis factor α than controls. In vitro T cell assays showed reduced proliferation, interferon-γ (IFNγ) production, and IL-17 production by lymph node cells from p38γ/δ(-/-) mice. IL-17 and IFNγ messenger RNA expression in joints was significantly inhibited in p38γ/δ(-/-) mice. Wild-type chimeric mice with p38γ/δ(-/-) bone marrow did not show decreased CIA. Reduced disease severity in p38γ/δ(-/-) mice was associated with lower cytokine production and anticollagen antibody responses than in controls, indicating that p38γ and p38δ are crucial regulators of inflammatory joint destruction in CIA. Our findings indicate that p38γ and p38δ are potential therapeutic targets in complex diseases, such as rheumatoid arthritis, that involve innate and adaptive immune responses.
Author Pérez‐Lorenzo, María J.
Risco, Ana
Alsina‐Beauchamp, Dayanira
Cuenda, Ana
Escós, Alejandra
Criado, Gabriel
Author_xml – sequence: 1
  givenname: Gabriel
  surname: Criado
  fullname: Criado, Gabriel
  organization: Instituto de Investigación Sanitaria and Hospital Universitario 12 de Octubre
– sequence: 2
  givenname: Ana
  surname: Risco
  fullname: Risco, Ana
  organization: Centro Nacional de Biotecnología, CSIC
– sequence: 3
  givenname: Dayanira
  surname: Alsina‐Beauchamp
  fullname: Alsina‐Beauchamp, Dayanira
  organization: Centro Nacional de Biotecnología, CSIC
– sequence: 4
  givenname: María J.
  surname: Pérez‐Lorenzo
  fullname: Pérez‐Lorenzo, María J.
  organization: Instituto de Investigación Sanitaria and Hospital Universitario 12 de Octubre
– sequence: 5
  givenname: Alejandra
  surname: Escós
  fullname: Escós, Alejandra
  organization: Centro Nacional de Biotecnología, CSIC
– sequence: 6
  givenname: Ana
  surname: Cuenda
  fullname: Cuenda, Ana
  organization: Centro Nacional de Biotecnología, CSIC
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24782184$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1OAjEUhRujEUQWvoCZxI0uBvrLzCwniErEaAyum1IuWjLMYNvRsPMRfEafxCqwIdpNu_jO6T33HKH9sioBoROCOwRj2lXWd1jKaLKHmpTRXiwoFvvbN8lIA7Wdm-NwsgT3sDhEDcqTlJKUN9FlXniwpfLmDaIlS6O7_OHWRbmFaOAclN6oIppVNupXRaGeofz6-ByW01rDNED-xRpv3DE6mKnCQXtzt9DT1WDcv4lH99fDfj6KNSdZEoPQGPiM6Mkkwz0tmEoEI4JCClglRFFBOQiumNBZKtI00SEf4WqqWcg00ayFzte-S1u91uC8XBinIQxWQlU7Gbww44IlLKBnO-i8qkPOIlDhV5phnvFAnW6oerKAqVxas1B2Jbf7CUB3DWhbOWdhJrXxYVlV6a0yhSRY_pQgQwnyt4SguNhRbE3_Yjfu76aA1f-gzB_Ha8U3HfqTIw
CitedBy_id crossref_primary_10_18632_oncotarget_6535
crossref_primary_10_3389_fmed_2022_849990
crossref_primary_10_3390_cells12131674
crossref_primary_10_1016_j_freeradbiomed_2016_06_001
crossref_primary_10_1007_s11010_017_3212_9
crossref_primary_10_3389_fcell_2016_00031
crossref_primary_10_3389_fimmu_2022_960544
crossref_primary_10_1007_s00281_014_0442_8
crossref_primary_10_1007_s10528_020_10016_9
crossref_primary_10_1016_j_intimp_2020_106823
crossref_primary_10_1155_2014_272689
crossref_primary_10_3389_fcell_2020_00189
crossref_primary_10_1016_j_intimp_2016_09_006
crossref_primary_10_1016_j_tibs_2017_02_008
crossref_primary_10_1093_brain_awad421
crossref_primary_10_1128_JVI_01100_19
crossref_primary_10_1016_j_fct_2015_08_017
crossref_primary_10_1186_s12974_016_0556_0
crossref_primary_10_18632_oncotarget_4320
crossref_primary_10_1002_mnfr_201500304
crossref_primary_10_3389_fcell_2023_1083033
crossref_primary_10_3389_fcell_2016_00067
crossref_primary_10_1038_s41573_020_0082_8
crossref_primary_10_1007_s00394_015_0850_0
crossref_primary_10_1158_0008_5472_CAN_14_0870
crossref_primary_10_1016_j_fct_2019_01_005
crossref_primary_10_1016_j_bbagen_2016_06_023
crossref_primary_10_3389_fimmu_2018_00065
crossref_primary_10_1016_j_ejphar_2014_08_031
crossref_primary_10_15252_embj_201591857
crossref_primary_10_1136_rmdopen_2015_000093
crossref_primary_10_1038_srep29881
crossref_primary_10_15252_emmm_201708485
crossref_primary_10_3390_cancers13092077
crossref_primary_10_1107_S1399004715001212
crossref_primary_10_3389_fphar_2018_00105
crossref_primary_10_3892_mmr_2015_3759
Cites_doi 10.1073/pnas.1207290109
10.1172/JCI36389
10.1186/ar2319
10.1002/art.11227
10.1038/sj.emboj.7600578
10.2174/1568026611313060003
10.1111/j.1600-065X.2008.00744.x
10.1016/j.ejphar.2004.11.013
10.1128/MCB.25.23.10454-10464.2005
10.1016/j.bbamcr.2007.03.010
10.1093/emboj/16.2.295
10.1007/BF02684010
10.1073/pnas.180316397
10.1002/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R
10.1002/art.34477
10.1124/jpet.108.139006
10.1002/art.22080
10.1002/art.34489
10.2174/1874312901206010209
10.1074/jbc.M414221200
10.1084/jem.154.3.688
10.1016/j.cellsig.2009.11.020
10.1084/jem.20120677
10.1002/art.21626
10.1084/jem.20070906
10.1002/art.24264
10.1042/BJ20070797
10.1016/j.clim.2009.03.522
10.4049/jimmunol.0901026
10.1073/pnas.0509188103
10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K
10.1038/nature01661
10.1016/j.molmed.2009.06.005
10.1073/pnas.1009234107
10.1016/j.ceb.2009.01.015
10.1016/S1097-2765(05)00014-6
10.1002/art.33359
10.1186/ar294
10.1084/jem.191.5.859
10.1002/art.34391
10.4049/jimmunol.0900483
10.1016/S0092-8674(00)00027-1
10.1038/nrd2829
10.4049/jimmunol.177.3.1913
ContentType Journal Article
Copyright Copyright © 2014 by the American College of Rheumatology
Copyright © 2014 by the American College of Rheumatology.
Copyright_xml – notice: Copyright © 2014 by the American College of Rheumatology
– notice: Copyright © 2014 by the American College of Rheumatology.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7T5
7TM
7U7
C1K
H94
K9.
7X8
DOI 10.1002/art.38327
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Nucleic Acids Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Toxicology Abstracts
Bacteriology Abstracts (Microbiology B)
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Calcium & Calcified Tissue Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList
Toxicology Abstracts
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2326-5205
EndPage 1217
ExternalDocumentID 3911919081
24782184
10_1002_art_38327
ART38327
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: MINECO FPI Fellowship
– fundername: Instituto de Salud Carlos III RETICS Programme
  funderid: RD08/0075 RIER
– fundername: MINECO Miguel Servet Fellowship
– fundername: Spanish Ministry of Economy and Competitiveness
  funderid: MINECO; CP07/250; BFU2010‐19734
GroupedDBID 0R~
1OC
24P
33P
3SF
4.4
52O
52U
52V
53G
5VS
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAQQT
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCUV
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZFZN
AZVAB
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
DCZOG
DIK
DRFUL
DRMAN
DRSTM
EBS
EJD
EMOBN
EX3
F00
FUBAC
G-S
G.N
GODZA
HGLYW
KBYEO
LATKE
LEEKS
LH4
LITHE
LOXES
LUTES
LW6
LYRES
MEWTI
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
NF~
O66
O9-
OK1
OVD
P2W
PQQKQ
QB0
ROL
SUPJJ
SV3
TEORI
V9Y
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WVDHM
WXSBR
YCJ
AAFWJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7T5
7TM
7U7
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
C1K
H94
K9.
7X8
ID FETCH-LOGICAL-c4197-e5c0e4f1cbb906c53a753152e8e0a71a2524e54a35c985887c00214adc3520bc3
ISSN 2326-5191
2326-5205
IngestDate Fri Jul 11 07:16:43 EDT 2025
Fri Jul 25 12:07:13 EDT 2025
Wed Feb 19 01:56:56 EST 2025
Tue Jul 01 00:33:09 EDT 2025
Thu Apr 24 23:05:22 EDT 2025
Wed Jan 22 16:21:14 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
Copyright © 2014 by the American College of Rheumatology.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4197-e5c0e4f1cbb906c53a753152e8e0a71a2524e54a35c985887c00214adc3520bc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 24782184
PQID 1753290494
PQPubID 946334
PageCount 10
ParticipantIDs proquest_miscellaneous_1520345373
proquest_journals_1753290494
pubmed_primary_24782184
crossref_citationtrail_10_1002_art_38327
crossref_primary_10_1002_art_38327
wiley_primary_10_1002_art_38327_ART38327
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate May 2014
PublicationDateYYYYMMDD 2014-05-01
PublicationDate_xml – month: 05
  year: 2014
  text: May 2014
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Atlanta
PublicationTitle Arthritis & rheumatology (Hoboken, N.J.)
PublicationTitleAlternate Arthritis Rheumatol
PublicationYear 2014
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2009; 21
2000; 6
2010; 107
2006; 54
2009; 60
2002; 51
2000; 43
2009; 132
2008; 327
2008; 205
2007; 408
2006; 177
2012; 109
2005; 24
2000; 191
2012; 209
2005; 25
2010; 22
2005; 280
2007; 1773
2000; 102
2013; 13
2000; 30
1981; 154
2000; 97
2007; 9
2008; 118
2003; 48
2009; 8
2005; 506
1997; 16
2009; 183
2001; 3
2003; 423
2009; 228
2012; 6
2009; 15
2012; 64
2006; 103
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_18_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_40_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_41_1
e_1_2_7_14_1
e_1_2_7_42_1
e_1_2_7_13_1
e_1_2_7_43_1
e_1_2_7_12_1
e_1_2_7_44_1
e_1_2_7_11_1
e_1_2_7_45_1
e_1_2_7_10_1
e_1_2_7_26_1
e_1_2_7_27_1
e_1_2_7_28_1
e_1_2_7_29_1
e_1_2_7_30_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_24_1
e_1_2_7_32_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_21_1
e_1_2_7_35_1
e_1_2_7_20_1
e_1_2_7_36_1
e_1_2_7_37_1
e_1_2_7_38_1
e_1_2_7_39_1
References_xml – volume: 25
  start-page: 10454
  year: 2005
  end-page: 64
  article-title: Generation and characterization of p38β (MAPK11) gene‐targeted mice
  publication-title: Mol Cell Biol
– volume: 13
  start-page: 705
  year: 2013
  end-page: 11
  article-title: Immunopathology of rheumatoid arthritis
  publication-title: Curr Top Med Chem
– volume: 107
  start-page: 14292
  year: 2010
  end-page: 7
  article-title: Proinflammatory T helper type 17 cells are effective B‐cell helpers
  publication-title: Proc Natl Acad Sci U S A
– volume: 8
  start-page: 480
  year: 2009
  end-page: 99
  article-title: Targeting innate immunity protein kinase signalling in inflammation
  publication-title: Nat Rev Drug Discov
– volume: 64
  start-page: 2147
  year: 2012
  end-page: 57
  article-title: Bone marrow–derived and synovium‐derived mesenchymal cells promote Th17 cell expansion and activation through caspase 1 activation: contribution to the chronicity of rheumatoid arthritis
  publication-title: Arthritis Rheum
– volume: 24
  start-page: 1134
  year: 2005
  end-page: 45
  article-title: p38γ regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP
  publication-title: EMBO J
– volume: 60
  start-page: 317
  year: 2009
  end-page: 20
  article-title: Inhibition of p38: has the fat lady sung?
  publication-title: Arthritis Rheum
– volume: 3
  start-page: 168
  year: 2001
  end-page: 77
  article-title: IL‐17 derived from juxta‐articular bone and synovium contributes to joint degradation in rheumatoid arthritis
  publication-title: Arthritis Res
– volume: 51
  start-page: 102
  year: 2002
  end-page: 4
  article-title: Overexpression of IL‐17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction
  publication-title: Inflamm Res
– volume: 132
  start-page: 295
  year: 2009
  end-page: 304
  article-title: Breaking old paradigms: Th17 cells in autoimmune arthritis
  publication-title: Clin Immunol
– volume: 54
  start-page: 2745
  year: 2006
  end-page: 56
  article-title: Differential tissue expression and activation of p38 MAPK α, β, γ, and δ isoforms in rheumatoid arthritis
  publication-title: Arthritis Rheum
– volume: 64
  start-page: 678
  year: 2012
  end-page: 87
  article-title: Decreased collagen‐induced arthritis severity and adaptive immunity in MKK‐6–deficient mice
  publication-title: Arthritis Rheum
– volume: 54
  start-page: 463
  year: 2006
  end-page: 72
  article-title: Activation of p38 MAPK is a key step in tumor necrosis factor–mediated inflammatory bone destruction
  publication-title: Arthritis Rheum
– volume: 9
  start-page: R113
  year: 2007
  article-title: Collagen‐induced arthritis in C57BL/6 mice is associated with a robust and sustained T‐cell response to type II collagen
  publication-title: Arthritis Res Ther
– volume: 183
  start-page: 5938
  year: 2009
  end-page: 47
  article-title: The α‐isoform of p38 MAPK specifically regulates arthritic bone loss
  publication-title: J Immunol
– volume: 6
  start-page: 109
  year: 2000
  end-page: 16
  article-title: Essential role of p38α MAP kinase in placental but not embryonic cardiovascular development
  publication-title: Mol Cell
– volume: 506
  start-page: 285
  year: 2005
  end-page: 95
  article-title: R‐130823, a novel inhibitor of p38 MAPK, ameliorates hyperalgesia and swelling in arthritis models
  publication-title: Eur J Pharmacol
– volume: 154
  start-page: 688
  year: 1981
  end-page: 700
  article-title: Type II collagen‐induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates
  publication-title: J Exp Med
– volume: 327
  start-page: 610
  year: 2008
  end-page: 9
  article-title: Pamapimod, a novel p38 mitogen‐activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity
  publication-title: J Pharmacol Exp Ther
– volume: 103
  start-page: 5484
  year: 2006
  end-page: 9
  article-title: Mitogen‐activated protein kinase kinase 3 is a pivotal pathway regulating p38 activation in inflammatory arthritis
  publication-title: Proc Natl Acad Sci U S A
– volume: 15
  start-page: 369
  year: 2009
  end-page: 79
  article-title: p38(MAPK): stress responses from molecular mechanisms to therapeutics
  publication-title: Trends Mol Med
– volume: 228
  start-page: 212
  year: 2009
  end-page: 24
  article-title: Regulation of the immune response by stress‐activated protein kinases
  publication-title: Immunol Rev
– volume: 64
  start-page: 2499
  year: 2012
  end-page: 503
  article-title: Inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis
  publication-title: Arthritis Rheum
– volume: 1773
  start-page: 1358
  year: 2007
  end-page: 75
  article-title: p38 MAP‐kinases pathway regulation, function and role in human diseases
  publication-title: Biochim Biophys Acta
– volume: 183
  start-page: 1360
  year: 2009
  end-page: 7
  article-title: Role of MAPK kinase 6 in arthritis: distinct mechanism of action in inflammation and cytokine expression
  publication-title: J Immunol
– volume: 64
  start-page: 2887
  year: 2012
  end-page: 95
  article-title: Antiinflammatory functions of p38 in mouse models of rheumatoid arthritis: advantages of targeting upstream kinases MKK‐3 or MKK‐6
  publication-title: Arthritis Rheum
– volume: 209
  start-page: 2229
  year: 2012
  end-page: 46
  article-title: Regulation of PTEN activity by p38δ‐PKD1 signaling in neutrophils confers inflammatory responses in the lung
  publication-title: J Exp Med
– volume: 205
  start-page: 331
  year: 2008
  end-page: 7
  article-title: Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases
  publication-title: J Exp Med
– volume: 22
  start-page: 660
  year: 2010
  end-page: 7
  article-title: Differential activation of p38MAPK isoforms by MKK6 and MKK3
  publication-title: Cell Signal
– volume: 109
  start-page: 11200
  year: 2012
  end-page: 5
  article-title: p38γ and p38δ kinases regulate the Toll‐like receptor 4 (TLR4)‐induced cytokine production by controlling ERK1/2 protein kinase pathway activation
  publication-title: Proc Natl Acad Sci U S A
– volume: 191
  start-page: 859
  year: 2000
  end-page: 70
  article-title: Deficiency of the stress kinase p38α results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme‐deficient embryonic stem cells
  publication-title: J Exp Med
– volume: 97
  start-page: 10454
  year: 2000
  end-page: 9
  article-title: Essential role for p38α mitogen‐activated protein kinase in placental angiogenesis
  publication-title: Proc Natl Acad Sci U S A
– volume: 280
  start-page: 19472
  year: 2005
  end-page: 9
  article-title: BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo
  publication-title: J Biol Chem
– volume: 30
  start-page: 1568
  year: 2000
  end-page: 75
  article-title: Collagen‐induced arthritis in C57BL/6 (H‐2 ) mice: new insights into an important disease model of rheumatoid arthritis
  publication-title: Eur J Immunol
– volume: 408
  start-page: 297
  year: 2007
  end-page: 315
  article-title: The selectivity of protein kinase inhibitors: a further update
  publication-title: Biochem J
– volume: 6
  start-page: 209
  year: 2012
  end-page: 19
  article-title: The p38 MAPK pathway in rheumatoid arthritis: a sideways look
  publication-title: Open Rheumatol J
– volume: 16
  start-page: 295
  year: 1997
  end-page: 305
  article-title: Activation of stress‐activated protein kinase‐3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6): comparison of the specificities of SAPK3 and SAPK2 (RK/p38)
  publication-title: EMBO J
– volume: 43
  start-page: 2501
  year: 2000
  end-page: 12
  article-title: Activation, differential localization, and regulation of the stress‐activated protein kinases, extracellular signal– regulated kinase, c‐JUN N‐terminal kinase, and p38 mitogen‐activated protein kinase, in synovial tissue and cells in rheumatoid arthritis
  publication-title: Arthritis Rheum
– volume: 118
  start-page: 3537
  year: 2008
  end-page: 45
  article-title: Evidence that cytokines play a role in rheumatoid arthritis
  publication-title: J Clin Invest
– volume: 21
  start-page: 317
  year: 2009
  end-page: 24
  article-title: Targeting protein kinases for the development of anti‐inflammatory drugs
  publication-title: Curr Opin Cell Biol
– volume: 48
  start-page: 2670
  year: 2003
  end-page: 81
  article-title: Prevention of the onset and progression of collagen‐induced arthritis in rats by the potent p38 mitogen‐activated protein kinase inhibitor FR167653
  publication-title: Arthritis Rheum
– volume: 423
  start-page: 356
  year: 2003
  end-page: 61
  article-title: Evolving concepts of rheumatoid arthritis
  publication-title: Nature
– volume: 177
  start-page: 1913
  year: 2006
  end-page: 7
  article-title: MAPKAP kinase 2‐deficient mice are resistant to collagen‐induced arthritis
  publication-title: J Immunol
– volume: 102
  start-page: 221
  year: 2000
  end-page: 31
  article-title: Requirement for p38α in erythropoietin expression: a role for stress kinases in erythropoiesis
  publication-title: Cell
– ident: e_1_2_7_23_1
  doi: 10.1073/pnas.1207290109
– ident: e_1_2_7_3_1
  doi: 10.1172/JCI36389
– ident: e_1_2_7_26_1
  doi: 10.1186/ar2319
– ident: e_1_2_7_10_1
  doi: 10.1002/art.11227
– ident: e_1_2_7_24_1
  doi: 10.1038/sj.emboj.7600578
– ident: e_1_2_7_44_1
  doi: 10.2174/1568026611313060003
– ident: e_1_2_7_8_1
  doi: 10.1111/j.1600-065X.2008.00744.x
– ident: e_1_2_7_11_1
  doi: 10.1016/j.ejphar.2004.11.013
– ident: e_1_2_7_29_1
  doi: 10.1128/MCB.25.23.10454-10464.2005
– ident: e_1_2_7_5_1
  doi: 10.1016/j.bbamcr.2007.03.010
– ident: e_1_2_7_25_1
  doi: 10.1093/emboj/16.2.295
– ident: e_1_2_7_38_1
  doi: 10.1007/BF02684010
– ident: e_1_2_7_31_1
  doi: 10.1073/pnas.180316397
– ident: e_1_2_7_27_1
  doi: 10.1002/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R
– ident: e_1_2_7_35_1
  doi: 10.1002/art.34477
– ident: e_1_2_7_12_1
  doi: 10.1124/jpet.108.139006
– ident: e_1_2_7_21_1
  doi: 10.1002/art.22080
– ident: e_1_2_7_34_1
  doi: 10.1002/art.34489
– ident: e_1_2_7_45_1
  doi: 10.2174/1874312901206010209
– ident: e_1_2_7_15_1
  doi: 10.1074/jbc.M414221200
– ident: e_1_2_7_28_1
  doi: 10.1084/jem.154.3.688
– ident: e_1_2_7_7_1
  doi: 10.1016/j.cellsig.2009.11.020
– ident: e_1_2_7_22_1
  doi: 10.1084/jem.20120677
– ident: e_1_2_7_41_1
  doi: 10.1002/art.21626
– ident: e_1_2_7_43_1
  doi: 10.1084/jem.20070906
– ident: e_1_2_7_13_1
  doi: 10.1002/art.24264
– ident: e_1_2_7_14_1
  doi: 10.1042/BJ20070797
– ident: e_1_2_7_37_1
  doi: 10.1016/j.clim.2009.03.522
– ident: e_1_2_7_20_1
  doi: 10.4049/jimmunol.0901026
– ident: e_1_2_7_18_1
  doi: 10.1073/pnas.0509188103
– ident: e_1_2_7_40_1
  doi: 10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K
– ident: e_1_2_7_2_1
  doi: 10.1038/nature01661
– ident: e_1_2_7_9_1
  doi: 10.1016/j.molmed.2009.06.005
– ident: e_1_2_7_39_1
  doi: 10.1073/pnas.1009234107
– ident: e_1_2_7_4_1
  doi: 10.1016/j.ceb.2009.01.015
– ident: e_1_2_7_30_1
  doi: 10.1016/S1097-2765(05)00014-6
– ident: e_1_2_7_17_1
  doi: 10.1002/art.33359
– ident: e_1_2_7_36_1
  doi: 10.1186/ar294
– ident: e_1_2_7_33_1
  doi: 10.1084/jem.191.5.859
– ident: e_1_2_7_42_1
  doi: 10.1002/art.34391
– ident: e_1_2_7_16_1
  doi: 10.4049/jimmunol.0900483
– ident: e_1_2_7_32_1
  doi: 10.1016/S0092-8674(00)00027-1
– ident: e_1_2_7_6_1
  doi: 10.1038/nrd2829
– ident: e_1_2_7_19_1
  doi: 10.4049/jimmunol.177.3.1913
SSID ssj0000970605
Score 2.3083973
Snippet Objective The role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38γ and p38δ deficiency in the...
The role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38γ and p38δ deficiency in the...
Objective The role of most p38 MAPK isoforms in inflammatory arthritis is not known. This study was undertaken to evaluate p38[gamma] and p38[delta] deficiency...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1208
SubjectTerms Animals
Arthritis
Arthritis, Experimental - metabolism
Collagen
Cytokines
Disease Models, Animal
Disease Progression
Female
Interferon-gamma - metabolism
Interleukin-17 - metabolism
Interleukin-1beta - metabolism
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Mitogen-Activated Protein Kinase 12 - deficiency
Mitogen-Activated Protein Kinase 12 - genetics
Mitogen-Activated Protein Kinase 12 - metabolism
Mitogen-Activated Protein Kinase 13 - deficiency
Mitogen-Activated Protein Kinase 13 - genetics
Mitogen-Activated Protein Kinase 13 - metabolism
Rodents
Tumor Necrosis Factor-alpha - metabolism
Title Alternative p38 MAPKs Are Essential for Collagen‐Induced Arthritis
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fart.38327
https://www.ncbi.nlm.nih.gov/pubmed/24782184
https://www.proquest.com/docview/1753290494
https://www.proquest.com/docview/1520345373
Volume 66
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLbKkBA3iP8VBgqIi0lVSuLYqXMZtkHpKJrQJu0uclxPrShJlTRI9IpH4F14I56E4596KR3S4CaKHDt2co7t79jnfEboVRxNwK4S3Fdk4GCgiNhnPBA-x7GADsIirr0Jxx_j4RkZndPzTudny2upWeZ9sboyruR_pAppIFcVJfsPknUvhQS4B_nCFSQM12vJOJ3b5byvsreIWG-cnhzXvbSSvaNaBRXNTHSiXh2AcaNwng3qwA618Z9Wy6lmNWpjVJeo1aKaygZQraFqAjg6LPPys7RRWqN-ayXhAL54olde3_EcLHDnu_FpVgsTTVO4SSCd17OCuwa9kbwRU_5lYfzsv_FiVrm8J2Y3v5Irl_9DWcliVdpoI_38kPdG_fYiRkguXQbNWAe4LvYBTJok2UrDAW0P1uaIFquUtDXyhjhgrVk8xCYkdGuGMIyzILI-2OaGlmCThfuP2dH5LBp-Z5xB0UwXvYFu4gEANoXE3x-7hb0gUYREVB9qaD9qzWgV4Neu4k0ctGXcbNpKGuyc3kV3rJXipUbl7qGOLO6jW2Prh_EAHbY0zwPN87TmQX7pOc3zQPO8teb9-v7D6pzn1OshOnt7dHow9O15HL4gYTLwJRWBJBehyPMkiAWNONi6gP8kkwEfhBxTTCQlPKIiYRRmL6EZ-fhEAMoPchE9QjtFWchd5F3wOIcpPyECUyInLIEiAC1pTAQTWLAu2l__nUxYsnp1Zso82xJDF710WReGoeWqTHvrX5zZDlxniqQWJ4ogqYteuMcwvKo9M17IsoE80PKI0GgQddFjIxpXCyYAr0MGpfe1rP5efQbGqb55cp3GPkW3L_vIHtpZVo18BtB3mT_XqvYbioekHA
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alternative+p38+MAPKs+Are+Essential+for+Collagen%E2%80%90Induced+Arthritis&rft.jtitle=Arthritis+%26+rheumatology+%28Hoboken%2C+N.J.%29&rft.au=Criado%2C+Gabriel&rft.au=Risco%2C+Ana&rft.au=Alsina%E2%80%90Beauchamp%2C+Dayanira&rft.au=P%C3%A9rez%E2%80%90Lorenzo%2C+Mar%C3%ADa+J.&rft.date=2014-05-01&rft.issn=2326-5191&rft.eissn=2326-5205&rft.volume=66&rft.issue=5&rft.spage=1208&rft.epage=1217&rft_id=info:doi/10.1002%2Fart.38327&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_art_38327
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2326-5191&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2326-5191&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2326-5191&client=summon